High-dose tenofovir is not effective in suppressing hepatitis B virus replication in patients with hepatocellular carcinoma progression: a preliminary result

BACKGROUNDS/AIMS: Nucleos(t)ide analogues (NUCs) effectively suppress hepatitis B virus (HBV) replication, but hepatocellular carcinoma (HCC) recurrence often leads to HBV replication despite NUC therapy. The aim of this study was to determine whether high-dose tenofovir (TNF) therapy can suppresses...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang, Shin, Song, Gi-Won, Jung, Dong-Hwan, Yoon, Young-In, Yoo, Hyun Ju, Tak, Eunyoung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association of Hepato-Biliary-Pancreatic Surgery 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4767269/
https://www.ncbi.nlm.nih.gov/pubmed/26925144
http://dx.doi.org/10.14701/kjhbps.2016.20.1.8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4767269/
https://www.ncbi.nlm.nih.gov/pubmed/26925144
http://dx.doi.org/10.14701/kjhbps.2016.20.1.8

Ejemplares similares